signal
pathway
facilit
metastasi
head
neck
squamou
cell
carcinoma
hnscc
cell
fulli
understood
transmembran
glycoprotein
known
induc
cell
migrat
invas
secret
peptid
also
known
promot
cell
metastasi
describ
import
migrat
invas
hnscc
cell
vitro
vivo
vitro
knockdown
decreas
cellular
prolifer
migrat
invas
vivo
knockdown
express
decreas
primari
tumor
growth
well
region
distant
metastasi
head
neck
squamou
cell
carcinoma
hnscc
aggress
malign
propens
invas
metastasi
despit
advanc
treatment
modal
prognosi
remain
poor
surviv
rate
fail
improv
contribut
treatment
challeng
underli
complex
diseas
pathogenesi
remain
larg
unknown
furthermor
abil
hnscc
cell
migrat
invad
result
signific
region
distant
metastasi
poor
patient
surviv
limit
abil
oncogen
cell
region
distantli
metastas
would
improv
diseas
control
outcom
order
oncogen
cell
migrat
invad
requir
capabl
anchorageindepend
growth
mean
break
compon
extracellular
matrix
basement
membran
abil
promot
format
new
blood
vessel
requir
facilit
also
known
extracellular
matrix
metalloproteinas
induc
cell
membran
bound
glycoprotein
express
sever
differ
type
oncogen
cell
allow
oncogen
cell
interact
support
cell
fibroblast
endotheli
cell
result
increas
express
matrix
metalloproteinas
mmp
hyaluronan
upregul
vascular
endotheli
growth
factor
result
promot
tumor
growth
metastasi
drug
resist
highli
express
squamou
cell
carcinoma
aris
sever
anatom
site
includ
head
neck
esophagu
lung
gastrointestin
track
previou
investig
found
high
level
express
hnscc
express
correl
tumor
progress
lymphat
metastasi
previous
investig
role
hnscc
cell
invas
found
express
hnscc
cell
result
increas
mmp
product
fibroblast
subsequ
collagen
degrad
tumor
microenviron
also
contain
secret
peptid
elev
express
found
malign
aris
varieti
anatom
site
includ
esophagu
breast
prostat
pancrea
lung
ovari
furthermor
found
enhanc
breast
cancer
metastasi
xenograft
exact
function
part
unknown
believ
act
chaperon
guid
misfold
protein
cell
sever
investig
tumor
progress
found
role
promot
cell
migrat
invas
end
investig
link
protein
metastasi
hnscc
cell
retrospect
review
patient
hnscc
perform
follow
institut
review
board
approv
univers
alabama
birmingham
tumor
histolog
confirm
patholog
depart
two
human
hnscc
tumor
cell
line
studi
fadu
atcc
manassa
va
jeffrey
myer
univers
texa
anderson
cancer
center
houston
texa
cell
obtain
grown
maintain
dulbecco
modifi
eagl
medium
dmem
contain
fetal
bovin
serum
fb
supplement
penicillin
streptomycin
cell
incub
co
gener
knockdown
sie
sia
hnscc
cell
line
describ
previous
briefli
short
hairpin
rna
shrna
lentivir
particl
deliveri
system
use
gener
tumor
cell
line
accord
manufactur
instruct
clontech
laboratori
inc
mountain
view
ca
dna
oligonucleotid
list
target
separ
clone
vector
vector
shrna
subsequ
packag
lentivir
particl
lentivir
particl
transduc
fadu
cell
select
puromycin
mgml
drugresist
cell
assess
flow
cytomet
express
confirm
western
blot
dna
sequenc
use
knockdown
antibodi
construct
univers
alabama
birmingham
tong
z
antibodi
murin
protein
g
affinitypurifi
buffer
pb
ph
preserv
ad
human
block
peptid
abnova
taipei
citi
taiwan
supplement
pepti
prospec
bio
rehovot
israel
purchas
commerci
imag
region
distant
metastasi
panitumumab
vectibix
amgen
thousand
oak
california
recombin
human
monoclon
antibodi
bind
specif
extracellular
domain
human
egfr
label
irdy
irdy
ester
licor
bioscienc
lincoln
nebraska
irdy
nearir
fluoresc
marker
label
process
perform
instruct
manufactur
briefli
antibodi
incub
irdy
reactiv
dye
potassium
phosphat
buffer
ph
hour
unconjug
irdy
remov
desalt
spin
column
thermo
fisher
scientif
inc
rockford
il
procedur
conduct
asept
techniqu
assess
effect
cell
prolifer
fadu
vector
control
knockdown
cell
plate
well
tissu
cultur
treat
plate
day
cell
treat
triplic
either
monoclon
antibodi
block
peptid
increas
concentr
nm
day
day
cell
trypsin
count
flow
cytomet
accuri
ann
arbor
mi
determin
role
hnscc
migrat
invas
transwel
chamber
system
use
cultrex
trevigen
inc
gaithersburg
md
top
chamber
well
contain
porou
membran
accord
manufactur
instruct
top
chamber
well
left
uncoat
migrat
coat
basement
membran
extract
bme
overnight
invas
cell
serum
starv
h
harvest
resuspend
dmem
fb
ml
plate
top
chamber
well
cellswel
excess
liquid
well
coat
bme
aspir
prior
plate
dmem
fb
ad
bottom
chamber
well
supplement
ad
top
bottom
chamber
ngml
addit
control
chamber
mitomycin
c
ad
top
well
h
halt
prolifer
chamber
system
incub
co
chamber
h
top
chamber
well
aspir
top
membran
scrap
remov
nonmigratori
noninvas
cell
bottom
side
membran
wash
wash
buffer
twice
allow
air
dri
min
membran
fix
methyl
alcohol
imeb
inc
san
marco
ca
approxim
sec
rins
di
water
stain
azur
solut
imeb
inc
san
marco
ca
approxim
sec
rins
di
water
allow
dri
dri
undersid
membran
view
microscop
cell
count
high
power
field
per
well
athym
femal
nude
mice
age
week
charl
river
laboratori
nation
cancer
institutefrederick
obtain
hous
accord
institut
institut
anim
care
use
committe
iacuc
guidelin
assess
role
metastasi
orthotop
tongu
tumor
model
establish
inject
fadu
cell
suspend
serumfre
dmem
proxim
tongu
cohort
divid
vector
control
knockdown
antibodi
treatment
n
per
group
treatment
cohort
treatment
ip
initi
time
tumor
cell
implant
administ
everi
h
week
tumor
measur
triweekli
use
calip
approxim
surfac
area
depth
imag
primari
lesion
lymph
node
metastasi
achiev
previous
describ
mice
system
inject
conjug
h
prior
euthan
time
euthanasia
mice
imag
use
pearl
impuls
licor
bioscienc
lincoln
nebraska
mice
place
supin
posit
arm
outstretch
pin
vertic
skin
incis
made
rib
cage
lip
cervic
skin
remov
bright
field
fluoresc
imag
head
neck
taken
predissect
postdissect
postexcis
primari
tumor
cervic
lymph
node
specimen
collect
patholog
analysi
pulmonari
metastat
model
nude
mice
system
inject
fadu
cell
line
describ
previous
briefli
hnscc
cell
resuspend
dmem
pb
inject
system
eleven
day
postinject
mice
system
inject
panitumumabirdy
day
mice
sacrif
lung
harvest
prior
prepar
histolog
process
lung
imag
use
pearl
imag
system
licor
bioscienc
lincoln
nebraska
primari
lesion
region
lymph
node
metastasi
mous
lung
fix
formalin
solut
fisher
scientif
pittsburgh
pa
one
hour
follow
ethanol
dehydr
tissu
embed
paraffin
wax
paraffin
section
thick
stain
hematoxylin
eosin
h
e
microscop
observ
sampl
rehydr
xylen
ethanol
ethanol
antigen
retriev
accomplish
mm
edta
ph
min
sampl
allow
cool
room
temperatur
block
bsa
tbst
min
room
temperatur
protocol
either
immunohistochem
immunofluoresc
stain
preform
see
immunohistochem
analysi
perform
determin
keratin
express
primari
antibodi
pan
cytokeratin
abcam
cambridg
appli
concentr
recommend
allow
incub
h
secondari
antibodi
horseradish
peroxidas
appli
h
humidifi
chamber
room
temperatur
dab
substrat
appli
slide
allow
incub
room
temperatur
appropri
color
develop
sampl
counterstain
harri
hematoxylin
dilut
tap
water
sec
final
sampl
dehydr
count
permount
allow
dri
overnight
immunofluoresc
analysi
perform
determin
express
section
incub
one
hour
room
temperatur
humidifi
chamber
antibodi
millipor
billerica
abcam
cambridg
slide
wash
time
trisbuff
ph
min
incub
dark
h
use
mixtur
fluorophorelink
secondari
antibodi
alexafluor
goat
antimous
alexafluor
goat
antirabbit
igg
invitrogen
grand
island
ny
slide
wash
time
trisbuff
ph
min
mount
use
gel
mount
aqueou
mount
medium
sigma
fluoresc
microscopi
perform
field
use
olympu
fluoresc
microscop
olympu
camera
imag
process
use
olympu
imag
softwar
cell
grown
confluenc
wash
twice
cold
pb
lyse
lysi
buffer
trishcl
nacl
vv
wv
sodium
deoxychol
edta
sd
proteas
inhibitor
cocktail
tablet
roch
appli
scienc
indianapoli
ad
clear
lysat
collect
centrifug
x
g
min
protein
concentr
measur
bca
protein
assay
thermo
scientif
rockford
il
lysat
total
protein
resolv
sd
page
transfer
pvdf
membran
membran
incub
primari
antibodi
wash
incub
horseradish
peroxidas
conjug
secondari
antibodi
membran
wash
detect
amersham
ecl
western
blot
detect
system
ge
healthcar
buckinghamshir
uk
membran
reprob
horseradish
peroxidaseconjug
mous
monoclon
antihuman
ensur
equal
protein
load
tumor
harvest
place
lysi
buffer
trishcl
nacl
vv
wv
sodium
deoxychol
edta
sd
plu
proteas
inhibitor
cocktail
roch
appli
scienc
indianapoli
sonic
clear
lysat
collect
centrifug
x
g
min
protein
concentr
measur
bca
protein
assay
thermo
scientif
rockford
il
sampl
mix
trisglycin
sd
buffer
novex
life
technolog
load
novex
zymogram
gel
gelatin
mm
well
electrophoresi
run
use
sd
run
buffer
hr
v
gel
renatur
zymogram
renatur
buffer
ml
novex
gentl
agit
room
temperatur
min
gel
develop
zymogram
develop
buffer
novex
gentl
agit
h
gel
wash
di
water
three
time
incub
simplyblu
safe
stain
life
technolog
day
clear
band
uniformli
stain
background
repres
area
gelatinolyt
activ
fb
load
control
data
analys
vitro
cell
growth
vivo
xenograft
growth
done
use
graphpad
prism
softwar
graphpad
softwar
inc
san
diego
ca
quantit
data
express
mean
standard
error
se
equat
volum
elliptoid
volum
length
width
depth
use
calcul
vivo
tongu
tumor
volum
p
consid
signific
unpair
ttest
analysi
use
determin
differ
group
western
blot
zymogram
band
intens
quantifi
use
imagej
http
rsbinfonihgovij
normal
betaactin
evalu
express
pattern
hnscc
immunofluoresc
analysi
clinic
tissu
specimen
perform
express
primarili
membran
immunoreact
predomin
cytoplasm
fig
approxim
half
oncogen
cell
demonstr
express
close
third
demonstr
immunoreact
furthermor
consist
previou
find
express
primarili
oncogen
cell
near
invad
front
cytoplasm
immunoreact
correl
membran
express
one
specimen
hnscc
tissu
specimen
correl
immunoreact
pattern
approxim
half
greater
cancer
cell
posit
stain
rel
protein
express
level
western
blot
analysi
verifi
knockdown
shrna
decreas
express
cell
line
rel
vector
control
vc
assess
express
found
knockdown
also
result
absenc
express
howev
knockdown
sia
slightli
decreas
express
increas
express
addit
knockdown
effect
express
fadu
fig
determin
effect
express
hnscc
cell
prolifer
fadu
vector
control
knockdown
cell
line
seed
triplic
grown
h
count
flow
cytomet
rel
vector
control
reduct
express
result
signific
decreas
cell
prolifer
p
similarli
treatment
monoclon
antibodi
significantli
decreas
prolifer
faduvc
cell
p
howev
treatment
effect
prolifer
knockdown
cell
line
fig
determin
block
reduc
prolifer
hnscc
cell
faduvc
cell
seed
triplic
incub
block
peptid
nm
h
treatment
significantli
decreas
cell
prolifer
concentr
p
significantli
decreas
faduvc
cell
prolifer
p
nm
p
concentr
fig
howev
similar
inhibit
cell
knockdown
express
significantli
decreas
prolifer
data
shown
migrat
bme
invas
bme
coat
evalu
transwel
chamber
system
bme
contain
sever
compon
found
basement
membran
laminin
collagen
iv
entactin
heparin
sulfat
proteoglycan
subsequ
serv
basement
membran
model
reduct
express
significantli
decreas
migrat
invas
fadu
knockdown
cell
compar
vector
control
p
fig
addit
media
affect
migrat
invas
faduvc
cell
line
howev
supplement
media
either
ngml
significantli
increas
invas
migrat
fadu
knockdown
cell
line
fig
support
hypothesi
supplement
compens
loss
suggest
codepend
role
primari
tumor
growth
cervic
lymph
node
metastasi
assess
use
oral
caviti
orthotop
tongu
model
fadu
vc
sie
cell
implant
proxim
tongu
athym
nude
mice
determin
effect
express
tumor
growth
rate
tumor
volum
measur
begin
day
postinocul
day
postinocul
significantli
larger
mean
tumor
volum
mm
compar
mm
p
mm
p
mm
p
reduc
growth
rate
maintain
conclus
studi
day
fig
signific
reduct
tumor
growth
rate
fadu
xenograft
compar
faduvc
day
postinocul
faduvc
xenograft
significantli
larger
tumor
volum
mm
compar
mm
p
mm
p
mm
p
fig
knockdown
fadu
cell
profound
reduct
tumor
growth
sever
xenograft
evid
diseas
time
vector
control
xenograft
requir
euthanasia
result
xenograft
region
lymph
node
resect
process
histolog
analys
target
fluoresc
imag
assist
local
diseas
fig
microscop
primari
lesion
lymph
node
metastasi
detect
h
e
confirm
probe
antihuman
cytokeratin
cervic
lymph
node
metastas
detect
xenograft
howev
signific
decreas
mean
number
posit
lymph
node
found
xenograft
inocul
knockdown
cell
rel
vector
control
p
p
p
fig
primari
lesion
underw
histolog
analys
express
fig
rel
signific
reduct
immunoreact
p
consist
vitro
data
knockdown
decreas
express
vivo
p
p
p
xenograft
rel
data
suggest
may
coregul
influenc
one
anoth
orthotop
xenograft
divid
two
cohort
control
treatment
treatment
ip
begun
day
tumor
cell
implant
day
signific
reduct
tumor
growth
rate
p
fig
reduct
tumor
growth
continu
durat
treatment
p
incid
posit
lymph
node
similar
two
cohort
howev
none
mice
treatment
cohort
evid
bln
metastasi
posit
bln
control
group
fig
primari
tumor
specimen
harvest
lysat
prepar
western
blot
zymogram
analysi
fig
trend
toward
decreas
p
p
express
treatment
group
furthermor
signific
decreas
activ
express
p
treatment
cohort
activ
express
similar
cohort
assess
effect
incid
distant
metastasi
fadu
cell
inject
system
nude
mice
day
follow
inject
cell
mous
lung
harvest
number
pulmonari
metastasi
seen
fluoresc
imag
confirm
histolog
analysi
trend
toward
lower
incid
pulmonari
metastasi
p
p
compar
supplement
fig
significantli
lower
incid
pulmonari
metastasi
p
p
compar
faduvc
supplement
fig
limit
understand
pathogenesi
allow
head
neck
oncogen
cell
metastas
previou
investig
lab
other
found
highli
express
hnscc
play
role
oncogen
cell
invas
furthermor
express
level
found
correl
progress
diseas
prognosi
lymph
node
metastasi
hnscc
howev
effect
region
distant
metastasi
hnscc
cell
vivo
yet
elucid
moreov
knowledg
relationship
metastasi
hnscc
previous
investig
studi
explor
relationship
provid
novel
data
support
role
promot
hnscc
tumorigenesi
metastasi
well
known
hnscc
cell
propens
invad
migrat
result
high
incid
region
distant
metastasi
decreas
surviv
prognosi
becom
increasingli
evid
abil
oncogen
cell
migrat
invad
depend
complex
set
interact
compon
tumor
microenviron
highli
glycosyl
transmembran
protein
behav
coordin
oncogen
cell
migrat
invas
via
regul
essenti
molecular
event
necessari
carcinogenesi
follow
malign
transform
normal
cell
oncogen
cell
facilit
phase
oncogenesi
promot
prolifer
induc
vegf
express
angiogenesi
stimul
proteolyt
enzym
express
enabl
anchorageindepend
growth
result
oncogen
cell
abl
migrat
invad
metastas
secret
peptid
also
found
promot
growth
metastasi
allow
anchorageindepend
growth
therefor
tumorigenesi
may
collabor
relationship
studi
demonstr
hnscc
cell
prolifer
tumor
growth
rate
metastasi
reduc
reduct
either
express
believ
increas
anchorageindepend
growth
oncogen
cell
permit
cell
migrat
seed
locat
appreci
distanc
primari
tumor
cell
popul
studi
effect
migrat
hnscc
cell
assess
abil
hnscc
cell
migrat
top
porou
membran
undersid
rel
vector
control
cell
line
found
knockdown
express
decreas
migratori
behavior
hnscc
p
furthermor
addit
media
increas
number
migratori
knockdown
cell
p
oncogen
cell
creat
pericellular
environ
contain
signal
agent
necessari
ensur
surviv
tumorigenesi
hnscc
cell
crosstalk
support
cell
fibroblast
tumor
microenviron
promot
mmp
express
facilit
cell
invas
induct
proteas
mmp
degrad
remodel
extracellular
matrix
result
oncogen
cell
abl
travers
basement
membran
extracellular
matrix
invad
region
distant
tissu
accord
express
found
significantli
higher
invas
front
hnscc
specimen
rel
differenti
core
sever
hnscc
specimen
studi
demonstr
similar
find
high
express
oncogen
cell
locat
near
invad
edg
order
simul
basement
membran
vitro
coat
porou
membran
basement
membran
extract
contain
type
iv
collagen
laminin
entactin
heparin
sulfat
proteoglycan
rel
vector
control
knockdown
significantli
reduc
abil
hnscc
cell
invad
travers
basement
membran
p
furthermor
addit
media
increas
number
invad
vector
control
cell
howev
supplement
media
increas
number
invad
knockdown
cell
rel
cell
expos
unsuppl
media
p
addit
knockdown
cell
expos
higher
concentr
demonstr
higher
rate
invas
fig
suggest
critic
element
invas
phenotyp
hnscc
cell
previous
demonstr
suppress
reduc
vivo
tumor
growth
via
downregul
oncogen
cell
prolifer
reduct
angiogenesi
investig
use
orthotop
model
assess
effect
express
incid
region
metastasi
knockdown
reduc
primari
tumor
growth
rate
xenograft
prevent
primari
growth
fadu
xenograft
histolog
analysi
lymph
node
xenograft
found
knockdown
reduc
number
posit
region
lymph
node
distant
metastas
addit
treatment
orthotop
xenograft
reduc
primari
tumor
growth
rate
incid
bilater
region
lymph
node
metastasi
knowledg
first
studi
explor
associ
metastasi
hnscc
vivo
find
indic
play
role
tumorigenesi
coincid
find
previou
investig
decreas
express
inhibit
reduc
hnscc
cell
prolifer
tumorigenesi
metastasi
order
elucid
util
oncogen
biomark
hnscc
investig
requir
improv
understand
intracellular
intercellular
mechan
play
may
valuabl
adjuv
therapeut
target
requir
explor
refer
web
version
pubm
central
supplementari
materi
investig
head
neck
squamou
cell
carcinoma
first
time
explor
relationship
first
time
appear
coloc
head
squamou
cell
carcinoma
sampl
knockdown
reduc
migrat
invas
vitro
knockdown
decreas
metastasi
vivo
express
pattern
hnscc
evalu
immunofluoresc
analysi
oral
caviti
squamou
cell
carcinoma
specimen
approxim
half
oncogen
cell
demonstr
express
close
third
demonstr
immunoreact
express
primarili
membran
immunoreact
predomin
cytoplasm
western
blot
analysi
protein
express
level
verifi
knockdown
express
fadusi
knockdown
express
sia
fadusia
cell
line
rel
vector
control
vc
addit
knockdown
correl
absenc
express
treatment
vector
control
cell
tx
effect
express
level
prolifer
fadu
vector
control
knockdown
sie
cell
line
b
assess
follow
h
rel
vector
control
reduct
express
result
signific
decreas
cell
prolifer
reduct
prolifer
faduvc
cell
line
follow
treatment
c
column
mean
triplic
bar
se
migrat
invas
evalu
transwel
chamber
system
reduct
express
significantli
decreas
migrat
invas
fadu
knockdown
cell
compar
vector
control
addit
media
affect
migrat
b
invas
c
faduvc
cell
line
howev
supplement
media
either
ngml
significantli
increas
migrat
b
invas
c
fadu
knockdown
cell
line
statist
signific
unpair
ttest
p
column
mean
triplic
bar
se
target
fluoresc
imag
assist
local
primari
diseas
lymph
node
metastasi
c
microscop
region
lymph
node
metastas
detect
xenograft
howev
signific
differ
number
posit
lymph
node
knockdown
cell
rel
vector
control
statist
signific
unpair
ttest
p
p
p
p
column
marker
mean
triplic
bar
se
orthotop
xenograft
divid
two
cohort
control
treatment
treatment
iptriweekli
begun
day
tumor
cell
implant
day
signific
reduct
tumor
growth
rate
incid
posit
lymph
node
similar
two
cohort
b
howev
none
mice
treatment
cohort
evid
bilater
lymph
node
bln
metastasi
posit
bln
control
group
b
lysat
primari
lesion
prepar
western
blot
zymogram
analysi
trend
toward
decreas
c
b
express
treatment
group
furthermor
signific
decreas
express
treatment
cohort
e
statist
signific
unpair
ttest
p
p
column
marker
mean
triplic
bar
se
